News

Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting ...
A virus that typically infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy—and ...
Calidi Biotherapeutics, Inc. ('Calidi” or the 'Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver ...
A virus from humble black-eyed peas is showing extraordinary promise in the fight against cancer. Unlike other plant viruses, ...
Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle ...
The viruses that kill bacteria may be our best bet against antibiotic resistance – if we can understand how they win.
A research team with Professor Neha Kamat used synthetic liposomes and bacterial extracts to generate immune responses ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
A virus that typically infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy-and researchers are uncovering why.
The cowpea mosaic virus could provide an affordable and effective immunotherapy treatment if clinical trials are successful.